Redmile Group, LLC Immunome Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q3 2024
A detailed history of Redmile Group, LLC transactions in Immunome Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 4,889,554 shares of IMNM stock, worth $46.4 Million. This represents 4.67% of its overall portfolio holdings.
Number of Shares
4,889,554
Previous 4,889,554
-0.0%
Holding current value
$46.4 Million
Previous $59.2 Million
20.83%
% of portfolio
4.67%
Previous 3.86%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
122Shares Held
47.1MCall Options Held
322KPut Options Held
1.91M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.76MShares$54.6 Million0.05% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$36.8 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$35.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$33.1 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.13MShares$29.7 Million0.0% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $115M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...